JayMac Pharmaceuticals Launches EnBrace HR: A Unique New Prenatal For High Risk Pregnancy

SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- Sunset, LA-based pharmaceutical company, JayMac Pharmaceuticals, has launched a first in class prenatal vitamin: EnBrace HR. For the thousands of women at risk of pregnancy complications such as infertility, miscarriage or giving birth to babies with birth defects this new product is the answer. EnBrace HR is the ONLY prenatal vitamin that meets Level A recommendations for amounts of folate needed for high risk pregnancy as cited by over 9 recommending bodies including the March of Dimes and the American College of Obstetrics and Gynecology.

Enbrace HR has 5 times more folates than the average prenatal vitamin-1000% daily value compared to 200% daily value:The largest study to date "Prevention of Neural Tube Defects-Results of the Medical Research Council Vitamin Study," was conducted in 33 centers in 7 countries in over 1800 women who had previously given birth to a child with a birth defect. In the group receiving higher levels of folic acid, 72% of birth defects were prevented.

EnBrace HR has diverse folates and covers ALL patient folate needs with folic acid, folinic acid, and L-methylfolate:EnBrace HR is ideal for patients with the MTHFR enzyme polymorphism, an enzyme deficiency present in as much as 60% of the US population which inhibits the metabolism of folate/folic acid into the active form needed for fetal development. EnBrace HR contains other needed ingredients such as b1, b2, b3, b6, b12, zinc, magnesium, chelate iron, and omega 3s. EnBrace HR is dosed in a small dime-size gelcap and is nausea-free.

Many studies have proven the link between high homocysteine and poor pregnancy outcomes:In a study of over 5000 pregnant women, high homocysteine was found to be correlated with lower birth rates, preeclampsia, and other pregnancy and birth complications: http://www.yourhealthbase.com/database/a102b.htm

EnBrace HR is proven to lower homocysteine, a toxic amino acid related to male and female infertility, repeated miscarriage, and giving birth to offspring with neural tube/birth defects, autism spectrum disorders, and neurodegenerative disorders. In a double-blind, placebo- controlled study of 330 patients with confirmed polymorphisms of the MTHFR enzyme, the compound in EnBrace HR dosed once a day lowered homocysteine levels by 32% over 8 weeks. Click here to access the full study.

Are You At High Risk?
Use this simple questionnaire to determine if EnBrace HR is right for you. Answer YES to 2 or more of the un-starred questions or Yes to 1 of the starred questions indicates a possible high risk pregnancy, requiring additional folates during preconception and pregnancy.

To request licensed prescriber samples of EnBrace HR, money saving prescription coupons or additional patient questionnaires contact EnBrace HR Customer Care: 985-778-5666.

EnBrace HR: Recommended Before, During, and After Pregnancy

CONTACT: Angela Hall JayMac Pharmaceuticals 850-602-1617Source:JayMac Pharmaceuticals